Clinical trial

Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects

NCT06015256

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention blood sample Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Characterization of Natural Killer Cells in Severe Asthma Patients in Comparison With Control Subjects

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-09-07

PhaseNA

Conditions

Asthma Acuteunresolved

Interventions

blood sampleBIOLOGICAL

Sponsors & collaborators

Institut National de la Santé Et de la Recherche Médicale, Francelead sponsor

Mapped research locations

MarseilleFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06015256 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.